A remedial signal for potentially harmful radiation that is emitted by a portable electronic battery powered communication device is implemented directly within the handset of the portable communication device the portable communication device is operated by a microprocessor and the remedial signal module is controlled by an algorithm in the microprocessor wherein the algorithm obtains information concerning radio frequency communications associated with the portable telecommunications device from the transceivers of the device.

Disclosed herein is a therapeutically active agent usable in the treatment of pulmonary arterial hypertension (PAH), for use in the treatment of pulmonary arterial hypertension, as well as methods of treating PAH, said treatment and methods comprising administering such an active agent and effecting pulmonary artery denervation in the subject. In some aspects, a sub-therapeutically effective amount of the active agent is administered. In some aspects, the method is devoid of administering such an active agent for at least one month subsequent to the denervation. Further disclosed is a method of treating PAH comprising determining a responsiveness of the subject to at least one therapeutically active agent usable in treating PAH; and effecting pulmonary artery denervation in a subject responsive to the active agent(s).

Disclosed herein is a therapeutically active agent usable in the treatment of pulmonary arterial hypertension (PAH), for use in the treatment of pulmonary arterial hypertension, as well as methods of treating PAH, said treatment and methods comprising administering such an active agent and effecting pulmonary artery denervation in the subject. In some aspects, a sub-therapeutically effective amount of the active agent is administered. In some aspects, the method is devoid of administering such an active agent for at least one month subsequent to the denervation. Further disclosed is a method of treating PAH comprising determining a responsiveness of the subject to at least one therapeutically active agent usable in treating PAH; and effecting pulmonary artery denervation in a subject responsive to the active agent(s).

A system for restoring muscle function to the lumbar spine to treat low back pain is provided. The system may include one or more electrode leads coupled to an implantable pulse generator (IPG) and a tunneler system for subcutaneously implanting a proximal portion of the lead(s). The system may also include a handheld activator configured to transfer a stimulation command to the IPG, and an external programmer configured to transfer programming data to the IPG. The stimulation command directs the programmable controller to stimulate the tissue in accordance with the programming data. The system may include a software-based programming system run on a computer such that the treating physician may program and adjust stimulation parameters.

A system for restoring muscle function to the lumbar spine to treat low back pain is provided. The system may include one or more electrode leads coupled to an implantable pulse generator (IPG) and a tunneler system for subcutaneously implanting a proximal portion of the lead(s). The system may also include a handheld activator configured to transfer a stimulation command to the IPG, and an external programmer configured to transfer programming data to the IPG. The stimulation command directs the programmable controller to stimulate the tissue in accordance with the programming data. The system may include a software-based programming system run on a computer such that the treating physician may program and adjust stimulation parameters.

A portable apparatus for generating an induced low-frequency sinusoidal electric current in an area of the human body includes four angular magnet sectors inscribed within the same circle, centered on the same axis of rotation, and spaced angularly apart from one another. The polarity of two adjacent angular magnet sectors is opposed, and a motor for rotating at a predetermined speed the angular magnet sectors is about the axis of rotation to generate an induced sinusoidal current at a predefined frequency. Each angular magnet sector includes the same geometrical shape with an internal angular opening of 90°, an external angular opening between 20° and 50°, and two lateral edges defining a radius extending over a distance, which is between one-third and two-thirds of a distance separating the axis of rotation from the free end of the magnet sectors.

Systems and methods for reducing blood viscosity along a flow direction, suppressing turbulence in blood flow, and treating rouleaux are disclosed. One method includes applying a unidirectional magnetic field to a flow of blood in a direction parallel or antiparallel to a direction of the flow of blood, and maintaining the application of the unidirectional magnetic field to the flow of blood until a blood viscosity along the direction of the flow of blood is reduced and/or the turbulence in the blood flow is suppressed. One system includes an annular magnet sized to encircle a portion of a patient's body. The magnet is adapted to generate a unidirectional magnetic field in a region within the annular magnet. The unidirectional magnetic field has a strength sufficient to reduce the blood viscosity in the portion of the patient's body and/or suppress turbulence in the blood flow by a predetermined amount. The system will also break rouleaux for patients with rouleaux, but the process will take more time. The blood viscosity reduction and turbulence suppression can make the blood flow laminar, lower the patient's blood pressure, cure hypertension, diminish heart murmur, and prevent development of astherosclerosis plaque in blood vessels. The curing rouleaux will improve the patient's blood oxygen function.

Systems and methods for reducing blood viscosity along a flow direction, suppressing turbulence in blood flow, and treating rouleaux are disclosed. One method includes applying a unidirectional magnetic field to a flow of blood in a direction parallel or antiparallel to a direction of the flow of blood, and maintaining the application of the unidirectional magnetic field to the flow of blood until a blood viscosity along the direction of the flow of blood is reduced and/or the turbulence in the blood flow is suppressed. One system includes an annular magnet sized to encircle a portion of a patient's body. The magnet is adapted to generate a unidirectional magnetic field in a region within the annular magnet. The unidirectional magnetic field has a strength sufficient to reduce the blood viscosity in the portion of the patient's body and/or suppress turbulence in the blood flow by a predetermined amount. The system will also break rouleaux for patients with rouleaux, but the process will take more time. The blood viscosity reduction and turbulence suppression can make the blood flow laminar, lower the patient's blood pressure, cure hypertension, diminish heart murmur, and prevent development of astherosclerosis plaque in blood vessels. The curing rouleaux will improve the patient's blood oxygen function.

A particle beam transport apparatus includes a vacuum duct, at least one magnet controller, and a scanning magnet. The vacuum duct is configured such that a particle beam advances through the vacuum duct. The magnet controller is disposed around a bent portion of the vacuum duct and is configured to control an advancing direction or shape of the particle beam. The scanning magnet is disposed on the downstream side of the magnet controller in the advancing direction and is configured to scan the particle beam by deflecting each bunch of the particle beam. The magnet controller includes a deflection magnet configured to deflect the advancing direction of the particle beam along the bent portion and a quadrupole magnet configured to converge the particle beam. The deflection magnet and the quadrupole magnet constitute a combined-function magnet arranged at the same point in the advancing direction.

A particle beam transport apparatus includes a vacuum duct, at least one magnet controller, and a scanning magnet. The vacuum duct is configured such that a particle beam advances through the vacuum duct. The magnet controller is disposed around a bent portion of the vacuum duct and is configured to control an advancing direction or shape of the particle beam. The scanning magnet is disposed on the downstream side of the magnet controller in the advancing direction and is configured to scan the particle beam by deflecting each bunch of the particle beam. The magnet controller includes a deflection magnet configured to deflect the advancing direction of the particle beam along the bent portion and a quadrupole magnet configured to converge the particle beam. The deflection magnet and the quadrupole magnet constitute a combined-function magnet arranged at the same point in the advancing direction.